2 recruiting, 1 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Neoadjuvant endocrine therapy: new trials by email Literature Review of Neoadjuvant endocrine therapy trials Research Report on Neoadjuvant endocrine therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer Neoadjuvant endocrine therapy - Breast Cancer, HER2-negative Breast Cancer | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 176 | 2026-03-13 | 2026-06-04 |
| Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) Neoadjuvant endocrine therapy - Breast Cancer Stage I, Breast Cancer Stage II | Phase 2 | Recruiting | George Washington University | 90 | 2024-10-01 | 2026-03-03 |
| Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients Neoadjuvant endocrine therapy, Neoadjuvant chemotherapy - Breast Cancer | Phase 3 | Terminated | Ruijin Hospital | 21 | 2016-03-01 | 2020-03-11 |
Breast Neoplasms (3) · Carcinoma (1) · Carcinoma, Lobular (1) · Neoplasms (1)
George Washington University (1) · Memorial Sloan Kettering Cancer Center (1) · Ruijin Hospital (1)
United States (2) · China (1)
Li Zhu, Prof (1)